Regulus Therapeutics: And The Attached Exhibit 99.1 Are Being Furnished And Shall Not Be Deemed Filed For The Purposes Of Section 18 Of The Securities And Exchange Act Of 1934, As Amended, Or Otherwise Subject To The Liabilities Of That Section. The Information In This Item 2.02 And The Attached Exhibit Shall Not Be Incorporated By Reference Into Any Registration Statement Or Other Document Pursuant To The Securities Act Of 1933, As Amended, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Regulus Therapeutics Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***